Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

439 results about "Prevalence" patented technology

Prevalence in epidemiology is the proportion of a particular population found to be affected by a medical condition (typically a disease or a risk factor such as smoking or seat-belt use). It is derived by comparing the number of people found to have the condition with the total number of people studied, and is usually expressed as a fraction, as a percentage, or as the number of cases per 10,000 or 100,000 people. Point prevalence is the proportion of a population that has the condition at a specific point in time. Period prevalence is the proportion of a population that has the condition at some time during a given period (e.g., 12 month prevalence), and includes people who already have the condition at the start of the study period as well as those who acquire it during that period. Lifetime prevalence (LTP) is the proportion of a population that at some point in their life (up to the time of assessment) have experienced the condition.

Computer-implemented medical analytics method and system employing a modified mini-max procedure

ActiveUS20090259494A1Simplify probabilistic determinationLimit natureFinanceForecastingDiseasePresent method
A method and system for medical analytics implemented on a computer and designed to aid a medical professional in diagnosing one or more diseases afflicting a patient. In contrast to prior art, the present method is based on using clinical data (m) that excludes subjective qualities of and also excludes prevalence of the one or more diseases (i). The method uses a knowledge base that contains disease (i) models exhibiting clinical data (m). Clinical data present (j) in the patient are input into the computer. Then, clinical data present (j) are matched with clinical data (m) in the knowledge base to enable the computer to compose a differential diagnosis list of ruled in diagnoses (k), where k=1 . . . n, for each of the disease (i) models that exhibits at least one clinical datum (m) that matches at least one clinical datum present (j) in the patient. In a key step, the computer computes a probability P(k) for each of the ruled in diagnoses (k) with the aid of a mini-max procedure that overcomes prior art limitations of the Bayes formulation and permits the analytics method to consider concurrent and competing diagnoses (k). Furthermore, the method composes pairs of clinical data present (j) and absent (r) in the patient to aid the medical professional in evaluating diagnoses and determining the most cost-effective clinical data to collect for conducting an effective and rapid diagnostic quest.
Owner:KNIDIAN INC

Bioinformatic Approach to Disease Diagnosis

Methods for constructing multivariate predictive models for diagnosing diseases for which test methods are individually inadequate, including: (a) performing laboratory tests on a statistically significant test population of individuals; (b) generating a score function from a linear combination of test panel results;
    • (c) performing a receiver operating characteristic (ROC) regression or alternative regression technique of the score function using those tests and β coefficients calculated simultaneously to maximize the area under the curve (AUC) of the function and chosen simultaneously to generate the largest area below that portion of the ROC curve for the (1−t0) quantile of individuals without disease, where t0 represents the maximum acceptable false-positive rate; (d) calculating individual pre-test disease odds; generating a diagnostic likelihood ratio of disease by determining the frequency of each individual's test score in the diseased population relative to the control population; and multiplying pre-test odds by the likelihood ratio to determine individual post-test disease odds; (e) converting a set of posttest odds into posttest probabilities for each potential multivariate methodology and creating an ROC curve for each methodology by altering posttest probability cutoff values; (f) comparing partial ROC areas generated by one or more regression techniques to determine the optimal methodology; and (g) dichotomizing the optimal methodology by finding that point on the ROC curve tangent to a line with slope (1−p) C/p·B, where p is population prevalence of disease, B is regret associated with failing to treat patients with disease and C is regret associated with treating a patient without disease.
Owner:PORWANCHER RICHARD

Medical guiding system based on body disease of patient

The invention discloses a medical service guiding system based on patient physical symptoms. The medical service guiding system comprises a client side system and a server system, wherein the client side system and the server system are connected with each other through a network. The client side system comprises a doctor information module, a department information module, a disease inquiry module, a symptom fuzzy reasoning module, a human body system guiding module, a human body part guiding module, a laboratory result module and a hospital planar graph module. Users can log into the medical service guiding system through a hospital terminal device or a personal handheld mobile device and select the corresponding modules to conduct inquiry; meanwhile, by setting up a symptom-department-doctor fuzzy reasoning model, newly-diagnosed patients can be helped to rapidly know prevalence of themselves according to the symptoms of themselves and find appropriate doctors in the unfamiliar environment, and therefore flexibility, accuracy and diagnostic efficiency are improved compared with an existing system. By means of the medical service guiding system, the current requirement of people for medical treatment and health is met, and the hospital service level and the service capacity are improved.
Owner:CHENGDU RUIGAN TECH

Penaeus vanmamei boone ecological culturing system

The invention relates to a penaeus vannamei boone ecological culturing system, which comprises a high level intensive culturing area, a circulating water passage, a shellfish culturing area, a salt-resistant plant area and a water quality treatment area, wherein the high level intensive culturing area, the shellfish culturing area, the salt-resistant plant area and the water quality treatment area are communicated by the circulating water passage. Before the penaeus vannamei boone is put into the system, bdellovibrio bacteria liquid and nitrifying bacteria are added into water of the high level intensive culturing area. During culturing, the traditional Chinese medicine liquid is added into the high level intensive culturing area. The system has the advantages that a culturing water body can be recycled, so the drainage of sewage is reduced, and the pressure on the ecological environment is reduced; the body immunity of the penaeus vannamei boone is improved, and the possibility of the disease outbreak and prevalence of the penaeus vannamei boone is reduced; the shellfishes, aquatic plants, mangroves and seaweeds are put into the system, so the economic benefit of culturing is improved; the whole culturing process realizes the culturing production without using antibiotics, the green and environment-friendly effects of the produced penaeus vannamei boone are realized, the mouth feel is similar to the taste of wild shrimps, and the penaeus vannamei boone is popular in market.
Owner:ZHEJIANG MARINE DEV RES INST

Femoral Arterial Cannula Capable of Guiding Bidirectional Perfusion Flow

ActiveUS20180043085A1Reduce the prevalenceStably carry-outOther blood circulation devicesCatheterArterial cannulationArterial cannula
The present invention relates to a cannula for femoral arterial bidirectional (a heart direction and a distal lower extremity direction) perfusion. The cannula, which has a cannula tube to be inserted into a blood vessel of the femoral artery, includes a perfusion guide channel formed as a concave part from a predetermined portion of an inner circumferential surface at an end of the cannula tube to the opposite end thereof in a length direction and further includes a through-hole provided at a boundary portion between the perfusion guide channel and the cannula tube in an end direction of the cannula tube, or includes a through-hole provided in a predetermined portion of to an inner circumferential surface of an end of the cannula tube and a guide cover provided at an upper portion of the through-hole to cover the upper portion of the through-hole and guide perfusion. During surgery, perfusion proceeds towards the distal limb and thus blood may be stably supplied, and thus ischemia prevalence of the distal limb may be significantly reduced. Accordingly, the cannula can replace conventional techniques used for distal limb perfusion and may stably perform femoral arterial cannulation without technical difficulties such as complications or breakage of blood vessels.
Owner:SAMSUNG LIFE PUBLIC WELFARE FOUND
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products